These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 14565901

  • 1. Bioterrorism and the nervous system.
    Han MH, Zunt JR.
    Curr Neurol Neurosci Rep; 2003 Nov; 3(6):476-82. PubMed ID: 14565901
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bioterrorism: management of major biological agents.
    Bossi P, Garin D, Guihot A, Gay F, Crance JM, Debord T, Autran B, Bricaire F.
    Cell Mol Life Sci; 2006 Oct; 63(19-20):2196-212. PubMed ID: 16964582
    [Abstract] [Full Text] [Related]

  • 7. Management of patients exposed to biologic weapons.
    Yetman RJ, Parks D, Taft E.
    J Pediatr Health Care; 2002 Oct; 16(5):256-61. PubMed ID: 12226595
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bioterrorism.
    Steinhauer R.
    RN; 2002 Mar; 65(3):48-54; quiz 55. PubMed ID: 11961869
    [No Abstract] [Full Text] [Related]

  • 10. Bioterrorism: pivotal clinical issues. Consensus review of the Society of Infectious Diseases Pharmacists.
    Terriff CM, Schwartz MD, Lomaestro BM, Society of Infectious Diseases Pharmacists.
    Pharmacotherapy; 2003 Mar; 23(3):274-90. PubMed ID: 12627924
    [Abstract] [Full Text] [Related]

  • 11. Medical aspects of bio-terrorism.
    Balali-Mood M, Moshiri M, Etemad L.
    Toxicon; 2013 Jul; 69():131-42. PubMed ID: 23339855
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recognition of illness associated with the intentional release of a biologic agent.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Oct 19; 50(41):893-7. PubMed ID: 11686473
    [Abstract] [Full Text] [Related]

  • 15. Preparing for bioterrorism: category A agents.
    Persell DJ, Arangie P, Young C, Stokes EN, Payne WC, Skorga P, Gilbert-Palmer D.
    Nurse Pract; 2001 Dec 19; 26(12):12-5, 19-24, 27; quiz 28-9. PubMed ID: 11809039
    [Abstract] [Full Text] [Related]

  • 16. Agents of bioterrorism. Preparing for bioterrorism at the community health care level.
    Miller JM.
    Infect Dis Clin North Am; 2001 Dec 19; 15(4):1127-56. PubMed ID: 11780270
    [Abstract] [Full Text] [Related]

  • 17. Bioterriorism: from threat to reality.
    Atlas RM.
    Annu Rev Microbiol; 2002 Dec 19; 56():167-85. PubMed ID: 12142472
    [Abstract] [Full Text] [Related]

  • 18. Clinical management of potential bioterrorism-related conditions.
    Adalja AA, Toner E, Inglesby TV.
    N Engl J Med; 2015 Mar 05; 372(10):954-62. PubMed ID: 25738671
    [Abstract] [Full Text] [Related]

  • 19. Bioterrorism.
    Bellamy RJ, Freedman AR.
    QJM; 2001 Apr 05; 94(4):227-34. PubMed ID: 11294966
    [No Abstract] [Full Text] [Related]

  • 20. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents.
    Cosgrove SE, Perl TM, Song X, Sisson SD.
    Arch Intern Med; 2005 Sep 26; 165(17):2002-6. PubMed ID: 16186470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.